SK

Saipriyanka Kommuri

Active Director Director DIN 08942771
DIN 08942771 First appointment Oct 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Saipriyanka Kommuri

Data last updated:

Saipriyanka Kommuri is a Director at Datta Bio Pharma Private Limited (since 2020). The company operates in Chemicals.

DIN 08942771
Primary Designation Director
Industry Chemicals
First Appointment 30 Oct 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Datta Bio Pharma Private Limited U24299TG2020PTC145446
Director30 Oct 20202020Active

Directorship timeline

Open interactive timeline →
Datta Bio Pharma Private Limited
Premium access

Shareholding and investment profile for Saipriyanka Kommuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saipriyanka Kommuri

Saipriyanka Kommuri currently holds 1 directorship: Datta Bio Pharma Private Limited (Director, since 30 Oct 2020).

Saipriyanka Kommuri was first appointed on 30 Oct 2020 as Director at Datta Bio Pharma Private Limited.

The current boards of Saipriyanka Kommuri's companies include Aruna Kommuri (Datta Bio Pharma Private Limited), Kommuri Divyasri (Datta Bio Pharma Private Limited), Nagapriyanka Reddy Sanvally (Datta Bio Pharma Private Limited), Prashanth Kommuri (Datta Bio Pharma Private Limited), Rakesh Kommuri (Datta Bio Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available